Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC56H71Cl2N7O12S |
InChIKeySLXVHAKRSWDHJT-NWMLSJNZSA-N |
CAS Registry2095244-56-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Japan | - | |
Neoplasms | Preclinical | Japan | - |